Are standard human coagulation tests suitable in pigs and calves during extracorporeal circulation?

Artificial Organs

Volumn 25, Issue 7, 2001, Pages 579-584

  Mueller, Xavier M ^a   Tevaearai, Hendrick T ^a   Jegger, David ^a   Tucker, Om ^a   Von Segesser, Ludwig K ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cardiopulmonary bypass; Cattle; Coagulation; Hematology; Swine

Indexed keywords

DEPOSITS; MAMMALS;

CARDIOPULMONARY BYPASS; CATTLE; COAGULATION TESTS; EXTRACORPOREAL CIRCULATION; HAEMATOLOGY; HEPARINIZATION; MEMBRANE OXYGENATORS; PARAMETER PROFILE; SWINE; THROMBOGENICITY;

COAGULATION;

HEPARIN;

ADULT; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BLOOD CLOTTING TEST; CARDIOPULMONARY BYPASS; CATTLE; COMPARATIVE STUDY; DISEASE MODEL; EXTRACORPOREAL CIRCULATION; HEMODYNAMICS; HUMAN; METHODOLOGY; MONITORING; PHYSIOLOGY; PROBABILITY; SENSITIVITY AND SPECIFICITY; SPECIES DIFFERENCE; SWINE; THROMBOEMBOLISM;

ADULT; ANALYSIS OF VARIANCE; ANIMALS; BLOOD COAGULATION TESTS; CARDIOPULMONARY BYPASS; CATTLE; DISEASE MODELS, ANIMAL; EXTRACORPOREAL CIRCULATION; HEMODYNAMIC PROCESSES; HEPARIN; HUMANS; MONITORING, PHYSIOLOGIC; PROBABILITY; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY; SWINE; THROMBOEMBOLISM;

EID: 0035406093     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2001.025007579.x     Document Type: Article

References (20)

1. Scott WJ, Rode R, Castelmain B, Kessler R, Follis F, Pett SB, Wernly JA. Efficacy, complication and cost of a comprehensive blood conservation program for cardiac operations. J Thorac Cardiovasc Surg 1992;103:1001-7.
2. Karges HE, Funk KA, Ronneberger H. Activity of coagulation and fibrinolysis parameters in animals. Arzneimittelforschung Drug Res 1994;44:793-7.
3. Von Lutze G, Hartzung K-J, Kurtschmann K. Aktivitätsbestimmungen von Einzelfaktoren der Gerinnung bei klinisch gesunden Schweinen und Rindern. Berl Munch Tierarztl Wochenschr 1992;105:411-4.
4. Kase F. Beitrag zum Vergleich des Gerinnungssystems beim Menschen, Kaninchen, Hund und Schwein. Folia Haematol Leipzig 1972;97:302-7.
5. von Segesser LK, Lachat M, Leskosek B, Turina M, Gallino A, von Felten A, Pei P. Cardiopulmonary bypass with low systemic heparinization: An experimental study. Perfusion 1990;5;267-75.
6. von Segesser, Turina M. Long term cardiopulmonary bypass without systemic heparinization. Int J Artif Organs 1990;13: 687-91.
7. von Segesser LK, Weiss BM, Pasic M, Leskosek B, von Felten A, Pei P, Turina M. Experimental evaluation of heparin-coated cardiopulmonary bypass equipment with low systemic heparinization and high-dose aprotinin. Thorac Cardiovasc Surg 1991;39:251-6.
8. von Segesser LK, Tkebuchava T, Leskosek B, Pei P, von Felten B, Turina M. Low prime, heparin coated centrifugal pumps. Perfusion 1995;10:177-82.
9. Gross DR. Thromboembolic phenomena and the use of the pig as an appropriate animal model for research on cardiovascular disease. Int J Artif Organs 1997;20:195-203.
10. Hahn N, Popov-Cenic S, Dorer A. Basiswerte von Blutgerinnungspaarametern des Hausschweins (Sus Scrofa domesticus). Berl Munch Tierarztl Wochenschr 1996;109:23-7.
11. von Segesser LK, Weiss BM, Hänseler E, Bisang B, Leskokesk B, von Felten A, Turina M. Improved biocompatibility of heparin surface-coated ventricular assist devices. Int J Artif Organs 1992;15:301-6.
12. Mueller XM, Marty B, Tevaearai HT, Tozzi PG, Jegger D, von Segesser LK. A siliconized hollow fiber membrane oxygenator. ASAIO J 2000;46:38-41.
13. Mueller XM, Tevaearai HT, Augstburger M, Horisberger J, von Segesser LK. Experimental evaluation of the Medtronic Maxima Forté hollow fiber membrane oxygenator. J Extra Corpor Technol 1998;30:115-9.
14. Addonizio VP Jr, Strauss FJ III, Colman R, Edmunds LH Jr. Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator. J Thorac Cardiovasc Surg 1979;77:119-26.
15. Weerasinghe A, Taylor KM. The platelet in cardiopulmonary bypass. Ann Thorac Surg 1998;66:2145-52.
16. Abrams CS, Ellison N, Budzysnski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990;75:128-38.
17. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein Iib/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332: 1553-9.
18. Rinder CS, Bonnert J, Rinder HM, Mitchell J, Ault K, Hillman R. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 1991;74:388-93.
19. Boisclair MD, Lane DA, Philippou H, Sheikh S, Hunt B. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1+2. Thromb Haemost 1993;70:253-8.
20. Gu YJ, van Oeveren W, van der Kamp KWHJ, Akkerman C, Boonstra PW, Wildevuur CRH. Heparin-coating of extracoporeal circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass. Perfusion 1991;6:221-5.